|
|
Volumn 8, Issue 3, 2001, Pages 597-603
|
|
A phase II trial of mitomycin C, 5′-deoxy-5-fluorouridine, etoposide and medroxyprogesterone acetate (McVD-MPA) as a salvage chemotherapy to anthracycline-resistant tumor in relapsed breast cancer and its mechanism(s) of antitumor action
a
|
|
Author keywords
5 dfur; Anthracycline resistance; Breast cancer; Medroxyprogesterone acetate; Mitomycin c; VP 16
|
|
Indexed keywords
ABC TRANSPORTER;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC ANTIBIOTIC;
DOXIFLURIDINE;
ETOPOSIDE;
FLOXURIDINE;
GLYCOPROTEIN P;
MEDROXYPROGESTERONE ACETATE;
MITOMYCIN;
MULTIDRUG RESISTANCE PROTEIN;
PRIMER DNA;
ADULT;
AGED;
ARTICLE;
BREAST TUMOR;
CHEMISTRY;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG RESISTANCE;
FEMALE;
HUMAN;
METABOLISM;
MIDDLE AGED;
PATHOLOGY;
PHASE 2 CLINICAL TRIAL;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
SALVAGE THERAPY;
TIME;
TUMOR RECURRENCE;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTIBIOTICS, ANTINEOPLASTIC;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ATP-BINDING CASSETTE TRANSPORTERS;
BREAST NEOPLASMS;
DNA PRIMERS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG RESISTANCE, NEOPLASM;
ETOPOSIDE;
FEMALE;
FLOXURIDINE;
HUMANS;
MEDROXYPROGESTERONE 17-ACETATE;
MIDDLE AGED;
MITOMYCIN;
MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS;
NEOPLASM RECURRENCE, LOCAL;
P-GLYCOPROTEINS;
REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;
SALVAGE THERAPY;
TIME FACTORS;
|
|
EID: 0035344474
PISSN: 1021335X
EISSN: None
Source Type: Journal
DOI: 10.3892/or.8.3.597 Document Type: Article |
|
Times cited : (4)
|
|
References (2)
|
